Gyre Therapeutics, Inc. (GYRE)
6.70
+0.01
(+0.15%)
USD |
NASDAQ |
Sep 16, 16:00
6.70
0.00 (0.00%)
After-Hours: 17:21
Gyre Therapeutics Total Liabilities (Quarterly) : 33.51M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.51M |
| March 31, 2026 | 24.19M |
| December 31, 2025 | 23.00M |
| September 30, 2025 | 21.97M |
| June 30, 2025 | 23.20M |
| March 31, 2025 | 25.49M |
| December 31, 2024 | 27.00M |
| September 30, 2024 | 26.77M |
| June 30, 2024 | 27.58M |
| March 31, 2024 | 33.24M |
| December 31, 2023 | 38.06M |
| September 30, 2023 | 6.447M |
| June 30, 2023 | 7.399M |
| March 31, 2023 | 11.39M |
| December 31, 2022 | 12.54M |
| September 30, 2022 | 1.644M |
| June 30, 2022 | 4.311M |
| March 31, 2022 | 13.19M |
| December 31, 2021 | 14.57M |
| September 30, 2021 | 17.80M |
| June 30, 2021 | 16.62M |
| March 31, 2021 | 14.99M |
| December 31, 2020 | 18.78M |
| September 30, 2020 | 17.74M |
| June 30, 2020 | 14.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.04M |
| December 31, 2019 | 30.22M |
| September 30, 2019 | 10.52M |
| June 30, 2019 | 7.762M |
| March 31, 2019 | 6.056M |
| December 31, 2018 | 4.975M |
| September 30, 2018 | 3.465M |
| June 30, 2018 | 2.579M |
| March 31, 2018 | 3.035M |
| December 31, 2017 | 8.739M |
| September 30, 2017 | 9.511M |
| June 30, 2017 | 9.284M |
| March 31, 2017 | 15.22M |
| December 31, 2016 | 22.02M |
| September 30, 2016 | 32.01M |
| June 30, 2016 | 33.74M |
| March 31, 2016 | 33.55M |
| December 31, 2015 | 38.10M |
| September 30, 2015 | 38.31M |
| June 30, 2015 | 1.643M |
| March 31, 2015 | 3.903M |
| December 31, 2014 | 3.456M |
| September 30, 2014 | 3.212M |
| June 30, 2014 | 7.497M |
| March 31, 2014 | 10.01M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cytokinetics, Inc. | 2.098B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.26M |
| Shareholders Equity (Quarterly) | 130.36M |
| Debt to Equity Ratio | 0.0262 |
| Current Ratio | 4.259 |
| Net Debt Paydown Yield | -0.05% |